Home/Filings/4/0001209191-20-042770
4//SEC Filing

Walsh Dennis Leo 4

Accession 0001209191-20-042770

CIK 0001654151other

Filed

Jul 16, 8:00 PM ET

Accepted

Jul 17, 4:00 PM ET

Size

5.7 KB

Accession

0001209191-20-042770

Insider Transaction Report

Form 4
Period: 2020-07-15
Transactions
  • Award

    Stock Option (Right to Buy)

    2020-07-15$34.58/sh+723$25,001723 total
    Exercise: $53.41Exp: 2030-07-15Common Stock (723 underlying)
Footnotes (1)
  • [F1]These options were issued upon election by the director to receive his cash board retainer fee for the second half of 2020 in the form of an equity award, in lieu of cash, under the amended and restated non-employee director compensation policy and 362 shares will vest on September 30, 2020 and 361 shares will vest on December 31, 2020, subject to the director's continued service on the board of directors, provided that, all shares shall become fully vested upon a change in control of the Company.

Issuer

Deciphera Pharmaceuticals, Inc.

CIK 0001654151

Entity typeother

Related Parties

1
  • filerCIK 0001713722

Filing Metadata

Form type
4
Filed
Jul 16, 8:00 PM ET
Accepted
Jul 17, 4:00 PM ET
Size
5.7 KB